SK
Sushma Kattamuri
About Sushma Kattamuri
Data last updated:
Sushma Kattamuri is a Director at Priche Generics Private Limited (since 2024), Director at Evertogen Life Sciences Limited (since 2022) and Director at Lytica Labs Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹186 Cr; the largest is Priche Generics Private Limited at ₹96.36 Cr (FY 2025). Earlier, Sushma Kattamuri was a Designated Partner at Northway Advisors Llp (2012–2024) and Director at Aryakube Capital Private Limited (2016) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Aug 2024 | 2016 | ₹96.36 Cr (FY 2025) | Active | |
| Director | 05 Jan 2022 | 2013 | ₹89.28 Cr (FY 2024) | Active | |
| Director | 02 Sep 2024 | 2017 | ₹13.5 Lakh (FY 2025) | Active | |
| Director | 13 Aug 2024 | 2002 | ₹6.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 06 Nov 2012 | 2012 | Active | ||
| Director | 19 Jan 2016 | 2016 | ₹5.40 Cr (FY 2025) | Active | |
| Director | 20 Jul 2010 | 2010 | Amalgamated | ||
| Director | 25 Apr 2016 | 2016 | ₹24,145 (FY 2017) | Strike Off | |
| Director | 29 Oct 2015 | 2015 | ₹29,997 (FY 2021) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sushma Kattamuri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Subbarao Kattamuri | 00107121 | Priche Generics Private Limited , Evertogen Life Sciences Limited and 2 more | Director |
| Akhila Thotapally | Evertogen Life Sciences Limited | Company Secretary | |
| Manav Jassal | 03059931 | Evertogen Life Sciences Limited | Director |
| Sat Paul Jassal | 07329650 | Evertogen Life Sciences Limited | Director |
| Sherifuddin Sheriff Shaik | 02201440 | Evertogen Life Sciences Limited | Director |
| Vikram Ravindra Mamidipudi | 00008241 | Evertogen Life Sciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushma Kattamuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushma Kattamuri
Sushma Kattamuri currently holds 4 directorships: Priche Generics Private Limited (Director, since 10 Aug 2024, revenue ₹96.36 Cr (FY 2025)); Evertogen Life Sciences Limited (Director, since 05 Jan 2022, revenue ₹89.28 Cr (FY 2024)); Lytica Labs Private Limited (Director, since 02 Sep 2024, revenue ₹13.5 Lakh (FY 2025)); K.R.R. Drugs & Intermediates Private Limited (Director, since 13 Aug 2024, revenue ₹6.3 Lakh (FY 2025)).
Sushma Kattamuri was first appointed on 20 Jul 2010 as Director at Gil Agrotech ( India ) Private Limited. The most recent appointment on record is 02 Sep 2024 at Lytica Labs Private Limited.
The 4 current companies of Sushma Kattamuri that report revenue have a combined latest revenue of ₹186 Cr: Priche Generics Private Limited ₹96.36 Cr (FY 2025); Evertogen Life Sciences Limited ₹89.28 Cr (FY 2024); Lytica Labs Private Limited ₹13.5 Lakh (FY 2025); K.R.R. Drugs & Intermediates Private Limited ₹6.3 Lakh (FY 2025).
Sushma Kattamuri held 5 earlier board appointments: Northway Advisors Llp (Designated Partner, 06 Nov 2012 to 16 Jul 2024); Aryakube Capital Private Limited (Director, 19 Jan 2016 to 20 May 2016); Gil Agrotech ( India ) Private Limited (Director, from 20 Jul 2010); Happy Advisory Services & Consulting Private Limited (Director, from 25 Apr 2016); Perfin Advisory Services Private Limited (Director, from 29 Oct 2015).
The current boards of Sushma Kattamuri's companies include Subbarao Kattamuri (Priche Generics Private Limited), Akhila Thotapally (Evertogen Life Sciences Limited), Manav Jassal (Evertogen Life Sciences Limited), Sat Paul Jassal (Evertogen Life Sciences Limited), Sherifuddin Sheriff Shaik (Evertogen Life Sciences Limited), Vikram Ravindra Mamidipudi (Evertogen Life Sciences Limited).